HAL vs LFCR · P/E 9.3, $19.05B cap vs $207.1M cap
Halliburton Company (HAL) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
LFCR does not have a complete income-statement cache yet.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the HAL and LFCR stock pages for the full models.
Not investment advice.